belapectin
Generic: GR-MD-02·Code: GR-MD-02
belapectin: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | Phase 2/Phase 3 |
Clinical Trials (1)
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Frequently asked questions
Who is developing belapectin?
belapectin is being developed by GALECTIN THERAPEUTICS INC.
How many clinical trials involve belapectin?
BioSniper tracks 1 clinical trial involving belapectin.
Get deeper analysis on belapectin
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis